Advantages: To arrest the dry AMD development the original low-light therapy during two sessions in the course of year was used. Methods: To apply the low-light therapy the Vision Aid Mark-III prototype was used to illuminate retina by three different wavelengths of light. To evaluate the optical density of the macular pigment, the MacuLux® Praxis (Ebiga VISION GmbH, Germany) was used. Effectiveness: The main group consist of 90...

Read More